Sabagh, M

The effect of Pringle maneuver in surgical outcome in patients underwent extended hepatectomy

Saborowski, A

Genetically flexible murine organoids for mechanistic and functional modeling of cholangiocarcinoma

Saborowski, M

Genetically flexible murine organoids for mechanistic and functional modeling of cholangiocarcinoma

Saez-Rodriguez, J

Novel short-termed mouse model of intrahepatic cholangiocarcinoma (ICC) by orthotopic transplantation of ICC cell line in C57/B6 mice

Sage, J

A targeted screen to identify relevant oncogenes in RAS activated liver cancer

Sahin, H

Genetic deletion of the chemokine Cxcl10 diminish HCC burden in a murine liver cancer model by modulation of tumor stroma

Sakin, V

A rapid point-of-care device for the diagnosis of Hepatitis Delta Virus infection

Salimi Alizei, E

Viral escape contributes to the failure of hepatitis D virus (HDV)-specific CD8+ T cells and drives population-level evolution of HDV

Phenotypic and functional differences of HBVcore- versus HBVpolymerase-specific CD8+ T cells in chronically HBV-infected patients with low viral load

Sànchez Munoz, A

Characterization of the liver phenotype of the BMP-9 knock-out mouse

Sandfort, V

SERPINA1 levels dictate TTR expression in HepG2 cells

Sauer, IM

Are preoperative laboratory parameters predictive for the metabolic function of primary human hepatocytes?

Sauer, P

Evaluation of serological markers of extracellular matrix remodeling in primary sclerosing cholangitis

Biliary calprotectin, lactoferrin and dimeric pyruvate kinase after liver transplantation are markers for biliary damage and predict graft survival

Sauerbruch, T

Varizenblutung oder Aszites: Was bewirkt den Unterschied?

Schaarschmidt, V

Hepatocellular autotaxin is a major source of systemic lysophosphatidic acid and regulates glucose homeostasis

Schachschal, G

Altered microbiota and bile acid composition in patients with primary sclerosing cholangitis

Schäfer, J

Sirtuin 6 regulates innate immune responses in a syngeneic mouse model of hepatocellular carcinoma

Schafmayer, C

Epigenomic map of human liver reveals principles of zonated morphogenic and metabolic control

Whole metabolome profiling identifies the combination of an eicosanoid, a bile acid and an androgen as a highly accurate marker of liver fibrosis in patients with non-alcoholic fatty liver disease

Loss of zonation in end stage liver disease revealed by in situ omics

Schakat, M

Visualization and analysis of inflammatory type T-cells in autoimmune hepatitis

Schattenberg, JM

Voluntary distance running prevents disease progression in mice with non-alcoholic fatty liver disease (NAFLD)

Lipid droplet-associated proteins in alcoholic and non-alcoholic steatohepatitis in patients with polymorphisms in PNPLA3

Baseline patient characteristics of the German multicentric prospective real-world NAFLD cohort: The Fatty Liver Assessment in Germany (FLAG) study

Schatz, P

Whole metabolome profiling identifies the combination of an eicosanoid, a bile acid and an androgen as a highly accurate marker of liver fibrosis in patients with non-alcoholic fatty liver disease

Schelbert, S

Lipid droplets and associated proteins in viral hepatitis

Scheller, J

B cell-mediated maintenance of CD169+ cells is critical for liver regeneration

Scherm, S

Innovative biomarkers detecting spontaneous bacterial peritonitis in ascitic fluid of liver cirrhosis patients

Schierwagen, R

Compartmentalization of immune response and microbial translocation in decompensated cirrhosis

Collagen type IV remodeling gender-specifically predicts mortality in decompensated liver cirrhosis

Schilcher, K

Gesättigte Fettsäure Palmitat induziert Amphiregulin durch Aktivierung von Stress induzierten Signalwegen wie PKC

Palmitic acid treatment alters expression of arachidonic-acid pathway associated genes in hepatoma cells linking fatty acids to inflammation

Schiller, F

Comparing 99mTc-mebrofenin scintigraphy and LiMAx-Test to assess presurgical functional liver capacitiy before major liver resection

Schilling, M

Prediction of Pathway Desensitization by Mathematical Modeling of IFNα Signal Transduction

Schindeldecker, M

Lipid droplets and associated proteins in viral hepatitis

Clinocopathologic correlation of alpha fetoprotein-expression in situ with serum levels in a large cohort of patients with hepatocellular carcinoma

Schirmacher, P

Lipid droplets and associated proteins in viral hepatitis

Acetaminophen (APAP)-induces a dynamic response of the Hippo pathway and its effector yes-associated protein (YAP) in hepatocellular cells

Lipid droplet-associated proteins in alcoholic and non-alcoholic steatohepatitis in patients with polymorphisms in PNPLA3

Cholangiocarcinogenesis is a developmental process driven by distinct sequential alterations of the cellular transcriptome

TAZ-inactivation partly compensates the phenotype caused by YAP knockdown in livers of YAP/TAZ-deficient mice

Protumorigenic stathmin expression in liver cancer is linked to karyopherin alpha 2-dependent import of E2F1 and TFDP1

RSPO2 gene rearrangement – a new cancer driver in the liver

MiRNAs involved in development of intraepithelial precursor lesions and progression to cholangiocarcinoma

The interaction of Serum Response Factor (SRF) and ETS domain transcription factors regulate the transcription of the MDM 4 oncogene in HCC

Mutation of PRSS23 promotes HCC development via activation of AKT/PI3K/mTOR signaling

Genetically flexible murine organoids for mechanistic and functional modeling of cholangiocarcinoma

Schlaak, J

Hepatitis B virus particles activate toll-like receptor 2 signaling initial upon infection of primary human hepatocytes

Schlattjan, M

Cholangiozyten haben eine phagozytische Funktion und zeigen darunter erhöhte metabolische Aktivität und Proliferationsraten

Schlitt, HJ

Induction of biliary epithelial wound healing and angiogenesis through IL6 in donor bile ducts after liver transplantation

Pharmacological treatment of hepatocellular cancer with cavoatrial tumor thrombus – case series and literature review

Schlosser, S

Innovative biomarkers detecting spontaneous bacterial peritonitis in ascitic fluid of liver cirrhosis patients

Reduced mucus layer and destabilized epithelial barrier – are these the first triggers driving spontaneous bacterial peritonitis?

Proliferation, migration and cell viability in hepatocellular carcinoma – what is the impact of IGFBP2?

Schlue, J

Senescence of T-Cells Increases with Fibrosis Progression in Chronic Viral Hepatitis

Schmid, RM

A targeted screen to identify relevant oncogenes in RAS activated liver cancer

Schmid, S

Delirium – of outstanding relevance for the interprofessional team on an intensive care unit with focus on hepatology

TIPS placed before current hospitalization and early admission to ICU increase survival of patients with cirrhosis and sepsis

Schmidt, A

Baseline patient characteristics of the German multicentric prospective real-world NAFLD cohort: The Fatty Liver Assessment in Germany (FLAG) study

An alternative model for prediction of transplant-free survival in patients with implantation of transjugular intrahepatic portosystemic shunt (TIPS): The Freiburg risk score

Schmidt, H

SERPINA1 levels dictate TTR expression in HepG2 cells

Schmidt-Arras, D

A novel mouse model to study effects of cell-autonomous gp130 activation on infection, inflammation and tumour formation in the liver

Schmiel, M

Metabolic Changes upon Inhibition of the Lysine-Specific-Demethylase-1 (LSD1) in Hepatocellular Carcinoma

Epigenitic Modifications by the Histone Demethylase LSD1 in Hepatic Stellate Cells Contribute to Liver Fibrosis

MiR-198 overexpression leads to its vesicular release from hepatocellular carcinoma cells

Schmithals, C

Hepatocellular autotaxin is a major source of systemic lysophosphatidic acid and regulates glucose homeostasis

Schmitt, J

Acetaminophen (APAP)-induces a dynamic response of the Hippo pathway and its effector yes-associated protein (YAP) in hepatocellular cells

TAZ-inactivation partly compensates the phenotype caused by YAP knockdown in livers of YAP/TAZ-deficient mice

Schmitt, V

Targeting mitochondrial dysfunction can restore antiviral activity of NK cells in HIV/HCV coinfection

Schmitt-Graeff, A

Inefficient induction of TAA-specific CD8+ T-cell responses in hepatocellular carcinoma

Schneider, A

Real-time monitoring of HBV-infection in mice revealed antigen level depended outcome of acute and chronic liver infection

The pivotal role of target cells in modulating efficacy of antiviral CD8 T cell immunity in the liver

Schneider, C

Protektiver Effekt von Statinen auf die Entstehung der heptischen Enzephalopathie ist abhängig von häufigen Genvarianten

Schneider, KM

A mouse model of chronic liver disease progression and acute-on-chronic liver failure

Intestinal dysbiosis drives liver disease progression via NLRP3 in the Mdr2-/- model of primary sclerosing cholangitis

Schneller, D

Hepatic Progenitor Cells/Oval Cells Mediate Pro-inflammatory Responses upon Liver Injuries

Schnieders, A

Characterization of immune cells in patients with liver cirrhosis with and without spontaneous bacterial peritonitis

Schnitzler, P

A rapid point-of-care device for the diagnosis of Hepatitis Delta Virus infection

Schocknecht, T

Monocytes as a potential trigger of Th17-differentiation in primary sclerosing cholangitis (PSC)

Scholtis, A

Recognition of bacteria by intestinal epithelial cells and regulation of p53 signaling and cell death – interactions at the epithelial interface leading to spontaneous bacterial peritonitis in liver cirrhosis

Schöneweis, K

Analysis of liver biopsies reveals a strong intrahepatic reduction of HDV and inflammatory markers after treatment with Myrcludex B in combination with Tenofovir in chronic HBV/HDV infected patients

Schönfels, W von

Epigenomic map of human liver reveals principles of zonated morphogenic and metabolic control

Whole metabolome profiling identifies the combination of an eicosanoid, a bile acid and an androgen as a highly accurate marker of liver fibrosis in patients with non-alcoholic fatty liver disease

Loss of zonation in end stage liver disease revealed by in situ omics

Schott, T

Loss of the middle hepatitis B virus (HBV) surface antigen (MHBs) during interferon-alpha (PEG-IFN) treatment is associated with subsequent lower HBV replication in patients with chronic HBeAg negative hepatitis B

Schramm, C

Metamizole: an underrated agent causing drug-induced liver injury (DILI) in Germany

Monocytes as a potential trigger of Th17-differentiation in primary sclerosing cholangitis (PSC)

Interferon-γ-dependent immune responses contribute to the pathogenesis of primary sclerosing cholangitis in mice

Visualization and analysis of inflammatory type T-cells in autoimmune hepatitis

Altered microbiota and bile acid composition in patients with primary sclerosing cholangitis

No significant impact of HCC surveillance on overall mortality – data from a tertiary referral center in Germany

Signifikante histologische Entzündungsaktivität trotz normwertiger Serum-ALT bei Patienten mit Autoimmuner Hepatitis und Leberzirrhose

Schubert, K

Metabolische Wirkungen mesenchymaler Stromalzellen in der nicht-alkoholischen Steatohepatitis

Schubert, L

Baseline patient characteristics of the German multicentric prospective real-world NAFLD cohort: The Fatty Liver Assessment in Germany (FLAG) study

Schuch, A

Phenotypic and functional differences of HBVcore- versus HBVpolymerase-specific CD8+ T cells in chronically HBV-infected patients with low viral load

Schulte, S

The damage of tight junction proteins in elder MDR 2-/- knockout mice: A question of cholestasis?

Schultheiss, M

Varizenblutung oder Aszites: Was bewirkt den Unterschied?

Inefficient induction of TAA-specific CD8+ T-cell responses in hepatocellular carcinoma

An alternative model for prediction of transplant-free survival in patients with implantation of transjugular intrahepatic portosystemic shunt (TIPS): The Freiburg risk score

Schulz, L

Metamizole: an underrated agent causing drug-induced liver injury (DILI) in Germany

Schulze, F

RSPO2 gene rearrangement – a new cancer driver in the liver

Schulze-Osthoff, K

Senescence of T-Cells Increases with Fibrosis Progression in Chronic Viral Hepatitis

Schulze-Pellengahr, S

Whole metabolome profiling identifies the combination of an eicosanoid, a bile acid and an androgen as a highly accurate marker of liver fibrosis in patients with non-alcoholic fatty liver disease

Schulze zur Wiesch, J

Viral escape contributes to the failure of hepatitis D virus (HDV)-specific CD8+ T cells and drives population-level evolution of HDV

Retherapie von Patienten mit chronischer Hepatitis-C Infektion nach Versagen einer Behandlung mit direct-acting agents (DAA)

Erste Erfahrung mit dem pangenotypischen Therapieregime Glecaprevir/Pibrentasvir (Maviret) zur Behandlung einer chronischen Hepatitis C Infektion

Krankheitsverständnis und Lebensqualität von Patienten mit chronischer Hepatitis B (HBV) Infektion mit und ohne antivirale Therapie

Schumacher, N

A novel mouse model to study effects of cell-autonomous gp130 activation on infection, inflammation and tumour formation in the liver

Schwarze-Zander, C

Targeting mitochondrial dysfunction can restore antiviral activity of NK cells in HIV/HCV coinfection

Schwarzkopf, K

Impaired adaptive immunity is an early event in liver cirrhosis preceding acute-on-chronic liver failure

Schwarzkopf, KM

IL-22 and IL22-binding protein are associated with development of and mortality from acute-on-chronic liver failure (ACLF)

Schweinoch, D

Tackling the HCV Life Cycle with Mathematical Modeling – Decoding the Enigma

Schwenzer, J

Baseline patient characteristics of the German multicentric prospective real-world NAFLD cohort: The Fatty Liver Assessment in Germany (FLAG) study

Schwinge, D

Monocytes as a potential trigger of Th17-differentiation in primary sclerosing cholangitis (PSC)

Interferon-γ-dependent immune responses contribute to the pathogenesis of primary sclerosing cholangitis in mice

Schwittai, I

Lipid droplet-associated proteins in alcoholic and non-alcoholic steatohepatitis in patients with polymorphisms in PNPLA3

Sebastian, M

Macrophage-hepatocyte crosstalk modulates hepcidin under physiological oxygen levels

Sebode, M

Metamizole: an underrated agent causing drug-induced liver injury (DILI) in Germany

Monocytes as a potential trigger of Th17-differentiation in primary sclerosing cholangitis (PSC)

Visualization and analysis of inflammatory type T-cells in autoimmune hepatitis

Signifikante histologische Entzündungsaktivität trotz normwertiger Serum-ALT bei Patienten mit Autoimmuner Hepatitis und Leberzirrhose

Seddek, A

A mouse model of chronic liver disease progression and acute-on-chronic liver failure

Seebach, J

Mutations in hepatitis B virus surface antigen during therapy with nucleic acid polymer REP 2139-Ca have no influence on treatment outcome or its detection by diagnostic assays

Seehawer, M

miR-193a-5 p regulates NUSAP1 expression to suppress hepatocarcinogenesis

Seehofer, D

Epigenomic map of human liver reveals principles of zonated morphogenic and metabolic control

Loss of zonation in end stage liver disease revealed by in situ omics

Seeßle, J

Phospho- and sphingolipid metabolism is altered in hereditary hemochromatosis independent of iron content and PNPLA3 polymorphism

Thrombelastometry in patients with acute-on-chronic liver failure

Seitz, HK

Liver stiffness decreases in response to portal pressure lowering drugs

Role of PNPLA3 rs738409 and MBOAT7 rs626283 during alcohol detoxification: Indication of different mechanisms for fibrosis development

Response of spleen stiffness to portal pressure lowering drugs in a rat model of cirrhosis

Critical flicker frequency improves after alcohol abstinence

Obesity negatively affects LS and CAP resolution after alcohol detoxification in heavy drinkers

Seitz, T

Fibroblast Growth Factor 9 is expressed by activated hepatic stellate cells and promotes progression of hepatocellular carcinoma

Seufferlein, T

Der Einsatz einer permanenten Aszitesdrainage bei Patienten mit therapierefraktärem Aszites bei Peritonealkarzinose und end-stage-Leberzirrhose: Vergleich des Komplikationen- und Sicherheitsprofils

Evaluation des Stellenwertes der cfDNA-Serumkonzentration für portale Hypertension bei Leberzirrhose

Shackel, N

Hepatitis B virus (HBV) DNA integration is not driven by viral proteins

Shafiei, S

The effect of Pringle maneuver in surgical outcome in patients underwent extended hepatectomy

Shang, R

MEK inhibition suppresses cholangiocarcinoma growth by restraining tumor cell proliferation and modulating tumor microenvironment

Shao, C

Transcription factor TRIM33 controls liver progenitor cell towards hepatocyte differentiation through synergizing with phosphorylated Smad2/3 in liver cirrhosis

Sharma, AD

Variants in TM6SF2, PNPLA3 and PCSK7 are risk factors for the development of cirrhosis in people with genetic haemochromatosis

Functional microRNA screening to improve hepatocyte formation via direct reprogramming

Sharma, R

Carriage of HSD17B13 rs72613567TA is associated with a reduced risk for developing hepatocellular carcinoma in patients with alcohol-related cirrhosis

Sheikh, N

Evaluation of hepatoprotective potential of Itraconazole in CCl4 induced liver injury mouse model

Investigation of hepatic and renal toxicity induced by omeprazole in CCl4 injury mouse model

Silva, I

Liver stiffness decreases in response to portal pressure lowering drugs

Role of PNPLA3 rs738409 and MBOAT7 rs626283 during alcohol detoxification: Indication of different mechanisms for fibrosis development

Response of spleen stiffness to portal pressure lowering drugs in a rat model of cirrhosis

Obesity negatively affects LS and CAP resolution after alcohol detoxification in heavy drinkers

Carriage of HSD17B13 rs72613567TA is associated with a reduced risk for developing hepatocellular carcinoma in patients with alcohol-related cirrhosis

Macrophage-hepatocyte crosstalk modulates hepcidin under physiological oxygen levels

Simon, KG

High real-world efficacy of elbasvir/grazoprevir (EBR/GZR) in genotype 1 (GT1) infected patients with and without liver cirrhosis: results from the German Hepatitis C Registry (DHC-R)

Simon, P

Voluntary distance running prevents disease progression in mice with non-alcoholic fatty liver disease (NAFLD)

Singer, S

Protumorigenic stathmin expression in liver cancer is linked to karyopherin alpha 2-dependent import of E2F1 and TFDP1

Singh, I

Dysregulated epigenetic factors in non-alcoholic fatty liver disease and triggered liver cancer

Sinha, A

The RNA binding protein HuR is a master regulator of hepatic-lipid homeostasis

Smedile, A

Viral escape contributes to the failure of hepatitis D virus (HDV)-specific CD8+ T cells and drives population-level evolution of HDV

Smits, M

Clearance of chronic HCV infection leads to an expansion of a follicular T helper cell memory phenotype in HCV-specific CD4 T cells

Combined OX40 stimulation and PD-L1 blockade reinforce HBV-specific CD4 T cell responses

Type I Interferons promote maintenance and function of follicular T helper cells in vitro

Socha, P

Common variant p.D19 H of the hepatobiliary sterol transporter ABCG5/8 increases the gallstone risk and affects cholesterol homeostasis in children

Soehnlein, O

The role of Formyl Peptide Receptor 1 in the development of non-alcoholic steatohepatitis

Sollors, J

Pharmacological treatment of hepatocellular cancer with cavoatrial tumor thrombus – case series and literature review

Sommer, J

Chain length and saturation status of fatty acids significantly affect cellular injury and lipid metabolism of primary human hepatocytes

Song, X

Loss of Axin1 induced hepatocarcinogenesis requires intact β-Catenin but not Notch cascade in mice

MEK inhibition suppresses cholangiocarcinoma growth by restraining tumor cell proliferation and modulating tumor microenvironment

Sonntag, R

Pharmacological inhibition of cyclin dependent kinase 2 inhibits proliferation and pro-fibrotic features of Hepatic Stellate Cells

Interventional targeting of Cyclin E1 during hepatocarcinogenesis limits stem cell traits and hepatic myeloid cell homing and attenuates cancer progression

Sörensen, A

Comparing 99mTc-mebrofenin scintigraphy and LiMAx-Test to assess presurgical functional liver capacitiy before major liver resection

Sowa, JP

Cholangiozyten haben eine phagozytische Funktion und zeigen darunter erhöhte metabolische Aktivität und Proliferationsraten

Spengler, U

Targeting mitochondrial dysfunction can restore antiviral activity of NK cells in HIV/HCV coinfection

Human intrahepatic ILC3 may modulate hepatic stellate cell activation

Carriage of HSD17B13 rs72613567TA is associated with a reduced risk for developing hepatocellular carcinoma in patients with alcohol-related cirrhosis

The ATG16L1 Gene Variant rs2241880 (p.T300A) Is Associated With Susceptibility to HCC In Patients with Cirrhosis

Spielberg, S

Genetically flexible murine organoids for mechanistic and functional modeling of cholangiocarcinoma

Spirk, M

Chemerin-156 reduces liver tumor growth in vivo but has no effect on liver cell proliferation and migration

Spitzley, S

Hepatitis C virus inhibits IL-1β-induced IκBζ expression in a Calpain-dependent manner resulting in LCN2 suppression

Spivak, I

In severe alcoholic hepatitis, serum transferrin predicts mortality independently of disease severity

Spormann, L

The interactions of Hedgehog and mTor signaling in Hepatocytes

Springer, J

An unexpected protective role for macrophages during hepatocellular carcinoma-associated cachexia

Stadler, M

Dysregulated epigenetic factors in non-alcoholic fatty liver disease and triggered liver cancer

Identification of Molecular Mechanisms by which NASH-derived Inflammation alters Hepatic Lipid Metabolism

Stallmach, A

Functional assessment of peritoneal mucosal associated invariant T (MAIT) cells in advanced cirrhosis

Hepatitis E is a frequent cause of severe acute liver injury – a tertiary referral center experience

The ATG16L1 Gene Variant rs2241880 (p.T300A) Is Associated With Susceptibility to HCC In Patients with Cirrhosis

Stancu, O

Spleen to liver stiffness ratio significantly differs between ALD and HCV and predicts disease-specific complications

Stefanescu, H

Spleen to liver stiffness ratio significantly differs between ALD and HCV and predicts disease-specific complications

Steffen, HM

The damage of tight junction proteins in elder MDR 2-/- knockout mice: A question of cholestasis?

No significant impact of HCC surveillance on overall mortality – data from a tertiary referral center in Germany

Steiger, K

Real-time monitoring of HBV-infection in mice revealed antigen level depended outcome of acute and chronic liver infection

Liver damage dampens anti-viral CD8 T cell response by inducing loss of surface T cell receptor expression

Interplay of caspase activation, calcium signaling and decreased mitochondria resilience enables viral clearance in the liver

A targeted screen to identify relevant oncogenes in RAS activated liver cancer

Stein, K

Baseline patient characteristics of the German multicentric prospective real-world NAFLD cohort: The Fatty Liver Assessment in Germany (FLAG) study

Stein, S

Monocytes as a potential trigger of Th17-differentiation in primary sclerosing cholangitis (PSC)

Steinebrunner, N

Pharmacological treatment of hepatocellular cancer with cavoatrial tumor thrombus – case series and literature review

Stellmacher, F

Quantification of hepatic liver iron overload with laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS)

Stengel, S

Functional assessment of peritoneal mucosal associated invariant T (MAIT) cells in advanced cirrhosis

The ATG16L1 Gene Variant rs2241880 (p.T300A) Is Associated With Susceptibility to HCC In Patients with Cirrhosis

Stenzinger, A

Cholangiocarcinogenesis is a developmental process driven by distinct sequential alterations of the cellular transcriptome

RSPO2 gene rearrangement – a new cancer driver in the liver

MiRNAs involved in development of intraepithelial precursor lesions and progression to cholangiocarcinoma

Stewart, S

Variants in TM6SF2, PNPLA3 and PCSK7 are risk factors for the development of cirrhosis in people with genetic haemochromatosis

Stickel, F

Epigenomic map of human liver reveals principles of zonated morphogenic and metabolic control

Variants in TM6SF2, PNPLA3 and PCSK7 are risk factors for the development of cirrhosis in people with genetic haemochromatosis

Whole metabolome profiling identifies the combination of an eicosanoid, a bile acid and an androgen as a highly accurate marker of liver fibrosis in patients with non-alcoholic fatty liver disease

Loss of zonation in end stage liver disease revealed by in situ omics

Carriage of HSD17B13 rs72613567TA is associated with a reduced risk for developing hepatocellular carcinoma in patients with alcohol-related cirrhosis

Stindt, J

Upregulation of TGR5 (Gpbar1) in macrophages protects mice from lipopolysaccharide and Listeria monocytogenes-induced liver damage

A Novel, Cell-Based Assay Allows Direct Measurement of Bile Salt Transport and Serves as Diagnostic Tool for Antibody-Induced BSEP Deficiency (AIBD)

Stindt, S

Hepatitis C virus inhibits IL-1β-induced IκBζ expression in a Calpain-dependent manner resulting in LCN2 suppression

Hepatitis C Virus mediates induction of CXC chemokine expression in response to the inflammatory cytokines TNFα and IL-1β

Stoehr, A

High real-world efficacy of elbasvir/grazoprevir (EBR/GZR) in genotype 1 (GT1) infected patients with and without liver cirrhosis: results from the German Hepatitis C Registry (DHC-R)

Stojkovic, M

Endocystectomy technique for surgical treatment of hepatic cystic echinococcosis

Stöpel, C

Wnt/β-Catenin and Hh signaling in the adult liver – an insight into distribution, interaction and regulation

Strand, D

Sirtuin 6 regulates innate immune responses in a syngeneic mouse model of hepatocellular carcinoma

Differential effect of TGF-β family members on proliferation and migration in primary liver cancer

Strand, S

Exploring molecular basis of therapy response in patient derived primary liver cancer cell lines

Sirtuin 6 regulates innate immune responses in a syngeneic mouse model of hepatocellular carcinoma

Strassburg, CP

Targeting mitochondrial dysfunction can restore antiviral activity of NK cells in HIV/HCV coinfection

Human intrahepatic ILC3 may modulate hepatic stellate cell activation

Collagen type IV remodeling gender-specifically predicts mortality in decompensated liver cirrhosis

Presence of sarcopenia is associated with development of acute-on-chronic liver failure in the NEPTUN cohort

Underdilation of controlled expansion transjugular intrahepatic portosystemic shunt (TIPS) preserves cardiac function and improves outcome

Straub, BK

Voluntary distance running prevents disease progression in mice with non-alcoholic fatty liver disease (NAFLD)

Lipid droplets and associated proteins in viral hepatitis

Lipid droplet-associated proteins in alcoholic and non-alcoholic steatohepatitis in patients with polymorphisms in PNPLA3

Exploring molecular basis of therapy response in patient derived primary liver cancer cell lines

Landscape of (epi-)genetic alterations during malignant transformation in liver cancer

Steatosis and associated proteins in hepatocellular adenoma

RSPO2 gene rearrangement – a new cancer driver in the liver

Clinocopathologic correlation of alpha fetoprotein-expression in situ with serum levels in a large cohort of patients with hepatocellular carcinoma

Stremmel, W

Phospho- and sphingolipid metabolism is altered in hereditary hemochromatosis independent of iron content and PNPLA3 polymorphism

Delivery of Copper-chelating Trientine (TETA) to the central nervous system

Strigli, A

Hepatocyte-derived calcineurin regulates the development of hepatocellular carcinoma independent of hepatic steatohepatitis

Strnad, P

In severe alcoholic hepatitis, serum transferrin predicts mortality independently of disease severity

Bei Patienten mit homozygotem Alpha1-Antitrypsinmangel (Pi*ZZ) ist die Substitution von Alpha1-Antitrypsin mit besseren Leberparametern assoziiert

Serum CYFRA 21 – 1 levels are elevated in advanced liver disease and associate with poor survival

Stroszczynski, C

Pharmacological treatment of hepatocellular cancer with cavoatrial tumor thrombus – case series and literature review

Strowig, T

Intestinal dysbiosis drives liver disease progression via NLRP3 in the Mdr2-/- model of primary sclerosing cholangitis

Strücker, B

Minimally invasive versus open hepatic resection for NEN liver metastasis: Case matched study with propensity score matching

Sturm, L

An alternative model for prediction of transplant-free survival in patients with implantation of transjugular intrahepatic portosystemic shunt (TIPS): The Freiburg risk score

Su, H

Intestinal dysbiosis drives liver disease progression via NLRP3 in the Mdr2-/- model of primary sclerosing cholangitis

Subramanian, P

The role of Formyl Peptide Receptor 1 in the development of non-alcoholic steatohepatitis

The RNA binding protein HuR is a master regulator of hepatic-lipid homeostasis

Sun, B

ECM1 is a gatekeeper that restrains TGF-β activation to maintain liver homeostasis and prevent fibrogenesis

Sundaram, B

B cell-mediated maintenance of CD169+ cells is critical for liver regeneration

Superti-Furga, G

Identification of host cell factors involved in hepatitis C virus replication

Sureau, C

Differential response of culture-derived HDV-1 and HDV-3 strains to peg-IFNα treatment in human liver chimeric mice despite strong ISG induction

Surewaard, BGJ

Platelet GPIba is a mediator and potential interventional target for NASH and subsequent liver cancer

Svetlana, H

Nierenperfusion und -steifigkeit als Marker unterschiedlicher renaler Auswirkungen der Leberzirrhose

Sydor, S

Low free triiodothyronine (fT3) is associated with advanced fibrosis in non-alcoholic steatohepatitis (NASH)

Auswirkung einer Binge Eating Episode auf Leberschädigung, den Gallensäuremetabolismus und Zelltodmarker

Syn, WK

Low free triiodothyronine (fT3) is associated with advanced fibrosis in non-alcoholic steatohepatitis (NASH)

Szydlowska, M

Platelet GPIba is a mediator and potential interventional target for NASH and subsequent liver cancer